Published in Am J Surg on April 01, 1977
A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest (1985) 2.26
Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J Clin Invest (1989) 1.87
Clinical review: Myocardial depression in sepsis and septic shock. Crit Care (2002) 1.74
Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J Clin Invest (1986) 1.34
Sepsis-induced cardiomyopathy. Curr Cardiol Rev (2011) 1.21
Is early ventricular dysfunction or dilatation associated with lower mortality rate in adult severe sepsis and septic shock? A meta-analysis. Crit Care (2013) 1.21
Sepsis-induced cardiomyopathy: a review of pathophysiologic mechanisms. Heart Fail Rev (2010) 1.18
Cardiovascular response to dobutamine stress predicts outcome in severe sepsis and septic shock. Crit Care (2008) 1.07
Myocardial cytokine IL-8 and nitric oxide synthase activity during and after resuscitation: preliminary observations in regards to post-resuscitation myocardial dysfunction. Resuscitation (2008) 0.92
Strain echocardiography identifies impaired longitudinal systolic function in patients with septic shock and preserved ejection fraction. Cardiovasc Ultrasound (2015) 0.83
Alterations of mitochondrial metabolism and protein concentrations in subacute septicemia. Infect Immun (1982) 0.83
Global end-diastolic volume increases to maintain fluid responsiveness in sepsis-induced systolic dysfunction. BMC Anesthesiol (2013) 0.79
The haemodynamics of septic shock. Intensive Care Med (1990) 0.78
Cardiopulmonary function following transfusion of three red blood cell products in elective abdominal aortic aneurysmectomy. Ann Surg (1981) 0.78
The impact of cardiac dysfunction on acute respiratory distress syndrome and mortality in mechanically ventilated patients with severe sepsis and septic shock: an observational study. J Crit Care (2014) 0.76
The Effect of Sepsis on the Erythrocyte. Int J Mol Sci (2017) 0.75
Hepatic--portal venous gas in adults: etiology, pathophysiology and clinical significance. Ann Surg (1978) 4.53
Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci U S A (1992) 3.72
Autologous transplantation of bone marrow cells improves damaged heart function. Circulation (1999) 3.17
Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med (1996) 2.67
The platelet function defect of cardiopulmonary bypass. Blood (1993) 2.63
Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol (1985) (1999) 2.13
Angiogenesis by endothelial cell transplantation. J Thorac Cardiovasc Surg (2001) 2.12
Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol (1982) 1.96
Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol (1998) 1.95
Does erythrocyte infusion improve 3.2-km run performance at high altitude? Eur J Appl Physiol Occup Physiol (1998) 1.94
In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A (1996) 1.90
Electrical alternans and cardiac electrical instability. Circulation (1988) 1.86
Aortic aneurysm repair. Reduced operative mortality associated with maintenance of optimal cardiac performance. Ann Surg (1980) 1.85
Excretion of deoxyribonucleic acid by lymphocytes stimulated with phytohemagglutinin or antigen. Proc Natl Acad Sci U S A (1972) 1.84
Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J Immunol (1992) 1.84
Deep sternal wound infection: risk factors and outcomes. Ann Thorac Surg (1998) 1.82
Nutritional outcome and pneumonia in critical care patients randomized to gastric versus jejunal tube feedings. The Critical Care Research Team. Crit Care Med (1992) 1.81
Postischemic renal injury is mediated by neutrophils and leukotrienes. Am J Physiol (1989) 1.77
Survival and function of bioengineered cardiac grafts. Circulation (1999) 1.72
Overexpression of transforming growth factor-beta1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy. Circulation (1997) 1.69
Guidelines for reporting morbidity and mortality after cardiac valvular operations. The American Association for Thoracic Surgery, Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Ann Thorac Surg (1996) 1.67
Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost (1994) 1.66
Neuropsychologic impairment after coronary bypass surgery: effect of gaseous microemboli during perfusionist interventions. J Thorac Cardiovasc Surg (2001) 1.64
Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol (1996) 1.58
Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil. Br J Surg (1991) 1.57
Cerebral microemboli during cardiopulmonary bypass: increased emboli during perfusionist interventions. Ann Thorac Surg (1999) 1.54
Hypothermia-induced reversible platelet dysfunction. Ann Surg (1987) 1.51
Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg (1995) 1.51
Guidelines for reporting morbidity and mortality after cardiac valvular operations. Eur J Cardiothorac Surg (1988) 1.50
The efficacy of sequential compression devices in multiple trauma patients with severe head injury. J Trauma (1994) 1.47
Autologous smooth muscle cell transplantation improved heart function in dilated cardiomyopathy. Ann Thorac Surg (2000) 1.47
Reperfusion pulmonary edema. JAMA (1989) 1.46
Safety and therapeutic effectiveness of reinfused shed blood after open heart surgery. Ann Thorac Surg (1994) 1.45
Insulin cardioplegia for elective coronary bypass surgery. J Thorac Cardiovasc Surg (2000) 1.44
Results of represervation of the chordae tendineae during redo mitral valve replacement. Ann Thorac Surg (1996) 1.41
Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of The American Association for Thoracic Surgery and The Society of Thoracic Surgeons. J Thorac Cardiovasc Surg (1996) 1.41
Predictors of low cardiac output syndrome after coronary artery bypass. J Thorac Cardiovasc Surg (1996) 1.40
Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid. J Thorac Cardiovasc Surg (1996) 1.39
Myocardial perfusion during warm antegrade and retrograde cardioplegia: a contrast echo study. Ann Thorac Surg (1999) 1.39
Platelet size as a determinant of platelet function. J Lab Clin Med (1983) 1.37
Total pancreatectomy of end-stage chronic pancreatitis. Ann Surg (1978) 1.35
Neutrophil and nonneutrophil-mediated injury in intestinal ischemia-reperfusion. Ann Surg (1993) 1.34
Restoration in vivo of erythrocyte adenosine triphosphate, 2,3-diphosphoglycerate, potassium ion, and sodium ion concentrations following the transfusion of acid-citrate-dextrose-stored human red blood cells. J Lab Clin Med (1969) 1.34
Consequences of postoperative alterations in respiratory mechanics. Am J Surg (1974) 1.34
Fifteen-year trends in risk severity and operative mortality in elderly patients undergoing coronary artery bypass graft surgery. Circulation (1998) 1.32
Arachidonic acid metabolism by platelets of differing size. Br J Haematol (1983) 1.29
Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. J Clin Invest (1996) 1.29
Results of combined pulmonary resection and cardiac operation. Ann Thorac Surg (1996) 1.24
Technique of successful clinical double-lung transplantation. Ann Thorac Surg (1988) 1.23
Infrared fibers for radiometer thermometry in hypothermia and hyperthermia treatment. IEEE Trans Biomed Eng (1989) 1.22
Platelet size and age determine platelet function independently. Blood (1984) 1.22
The relation between response to hypotonic stress and the 51Cr recovery in vivo of preserved platelets. Transfusion (1974) 1.21
Microvascular pericyte contractility in vitro: comparison with other cells of the vascular wall. J Cell Biol (1987) 1.21
Cardiomyocyte transplantation improves heart function. Ann Thorac Surg (1996) 1.20
Platelet size does not correlate with platelet age. Blood (1983) 1.19
Pulmonary edema after aneurysm surgery is modified by mannitol. Ann Surg (1989) 1.19
Smooth muscle cell transplantation into myocardial scar tissue improves heart function. J Mol Cell Cardiol (1999) 1.19
Effect of 24-hour whole-blood storage on plasma clotting factors. Transfusion (1999) 1.18
Unwashed filtered shed blood collected after knee and hip arthroplasties. A source of autologous red blood cells. J Bone Joint Surg Am (1991) 1.16
Guidelines on admission and discharge for adult intermediate care units. American College of Critical Care Medicine of the Society of Critical Care Medicine. Crit Care Med (1998) 1.16
The role of anticoagulation in the measurement of platelet volumes. Am J Clin Pathol (1983) 1.15
Future directions of vitamin E and its analogues in minimizing myocardial ischemia-reperfusion injury. Can J Cardiol (1993) 1.14
Serotonin, norepinephrine, and histamine mediation of endothelial cell barrier function in vitro. J Cell Physiol (1986) 1.14
Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Ann Thorac Surg (2001) 1.13
Evaluation of autologous shed blood for autotransfusion after orthopaedic surgery. Clin Orthop Relat Res (1994) 1.13
Red-cell 2,3-diphosphoglycerate and creatine levels in patients with red-cell mass deficits or with cardiopulmonary insufficiency. N Engl J Med (1969) 1.13
Phalloidin enhances endothelial barrier function and reduces inflammatory permeability in vitro. Microvasc Res (1988) 1.13
Blockade of complement activation prevents local and pulmonary albumin leak after lower torso ischemia-reperfusion. Ann Surg (1992) 1.13
Ischaemia-reperfusion is an event triggered by immune complexes and complement. Br J Surg (2003) 1.12
Eicosanoid modulation of stress fibers in cultured bovine aortic endothelial cells. Inflammation (1985) 1.11
Current concepts measurement of cardiac output by thermodilution. N Engl J Med (1975) 1.10
Natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue. Circulation (1997) 1.10
Pulmonary leukosequestration induced by hind limb ischemia. Ann Surg (1987) 1.09
Role for tumor necrosis factor as mediator of lung injury following lower torso ischemia. J Appl Physiol (1985) (1991) 1.09
Induction of platelet formation from megakaryocytoid cells by nitric oxide. Proc Natl Acad Sci U S A (2001) 1.08
Prostacyclin and thromboxane A2 moderate postischemic renal failure. Surgery (1985) 1.08
The changing pattern of reoperative coronary surgery: trends in 1230 consecutive reoperations. J Thorac Cardiovasc Surg (2000) 1.08
Construction of a bioengineered cardiac graft. J Thorac Cardiovasc Surg (2000) 1.08
Maintenance of cardiodynamics with aspirin during abdominal aortic aneurysmectomy (AAA). Ann Surg (1981) 1.08
Cell transplantation comes of age. J Thorac Cardiovasc Surg (2001) 1.07
Massive transfusion in patients with severe traumatic injuries. Vox Sang (2009) 1.06
The effects of complement activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilution. Ann Surg (1988) 1.05
Prostacyclin reversal of lethal endotoxemia in dogs. J Clin Invest (1981) 1.05
Treatment of pulmonary embolism with prostacyclin. Surgery (1980) 1.04
Adenosine myocardial protection: preliminary results of a phase II clinical trial. Ann Surg (1999) 1.03
The fate of a tissue-engineered cardiac graft in the right ventricular outflow tract of the rat. J Thorac Cardiovasc Surg (2001) 1.03